Semler Group

Semler Scientific is a healthcare technology company focused on developing and marketing proprietary products and services that assist healthcare providers in the early detection and monitoring of chronic diseases. The company's flagship product, QuantaFlo, is a rapid, non-invasive point-of-care digital sensor and software solution used to screen for peripheral arterial disease (PAD) by measuring blood flow in the extremities. Semler's business model primarily involves providing QuantaFlo to insurance companies, physician groups, and health systems under a subscription or fee-per-test arrangement. Recently, the company gained significant attention for adopting Bitcoin as a primary treasury reserve asset, similar to the strategy employed by MicroStrategy. Semler Scientific continues to explore additional applications for its technology in other chronic disease states, including heart failure and kidney disease.